291 related articles for article (PubMed ID: 28847270)
1. Development of Timolol Maleate Loaded Chitosan Nanoparticles For Improved Ocular Delivery.
Saroha A; Pandey P; Kaushik D
Pharm Nanotechnol; 2017; 5(4):310-316. PubMed ID: 28847270
[TBL] [Abstract][Full Text] [Related]
2. Chitosan derivatives as effective nanocarriers for ocular release of timolol drug.
Siafaka PI; Titopoulou A; Koukaras EN; Kostoglou M; Koutris E; Karavas E; Bikiaris DN
Int J Pharm; 2015 Nov; 495(1):249-264. PubMed ID: 26341322
[TBL] [Abstract][Full Text] [Related]
3. Development and Characterization of Gefitinib Loaded Polymeric Nanoparticles by Ionic Gelation Method.
Gupta M; Marwaha RK; Dureja H
Pharm Nanotechnol; 2017; 5(4):301-309. PubMed ID: 28982345
[TBL] [Abstract][Full Text] [Related]
4. Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma.
Ilka R; Mohseni M; Kianirad M; Naseripour M; Ashtari K; Mehravi B
Int J Biol Macromol; 2018 Apr; 109():955-962. PubMed ID: 29154878
[TBL] [Abstract][Full Text] [Related]
5. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
Shah B; Khunt D; Misra M; Padh H
Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654
[TBL] [Abstract][Full Text] [Related]
6. Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery.
Zhao R; Li J; Wang J; Yin Z; Zhu Y; Liu W
AAPS PharmSciTech; 2017 May; 18(4):997-1008. PubMed ID: 28101726
[TBL] [Abstract][Full Text] [Related]
7. Chitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate:
Aljaeid BM; El-Say KM; Hosny KM
Drug Dev Ind Pharm; 2019 Jul; 45(7):1130-1139. PubMed ID: 30884977
[No Abstract] [Full Text] [Related]
8. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
Sharma M; Sharma R; Jain DK; Saraf A
Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197
[TBL] [Abstract][Full Text] [Related]
9. Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in-vivo efficacy and safe histological profile.
Shokry M; Hathout RM; Mansour S
Int J Pharm; 2018 Jul; 545(1-2):229-239. PubMed ID: 29709617
[TBL] [Abstract][Full Text] [Related]
10. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME
Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871
[TBL] [Abstract][Full Text] [Related]
11. Chitosan nanoparticles for prolonged delivery of timolol maleate.
Agnihotri SA; Aminabhavi TM
Drug Dev Ind Pharm; 2007 Nov; 33(11):1254-62. PubMed ID: 18058322
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-Gelatin Hydrogel Crosslinked With Oxidized Sucrose for the Ocular Delivery of Timolol Maleate.
El-Feky GS; Zayed GM; Elshaier YAMM; Alsharif FM
J Pharm Sci; 2018 Dec; 107(12):3098-3104. PubMed ID: 30165067
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma.
Tighsazzadeh M; Mitchell JC; Boateng JS
Int J Pharm; 2019 Jul; 566():111-125. PubMed ID: 31129346
[TBL] [Abstract][Full Text] [Related]
14. Stimulus Responsive Ocular Gentamycin-Ferrying Chitosan Nanoparticles Hydrogel: Formulation Optimization, Ocular Safety and Antibacterial Assessment.
Alruwaili NK; Zafar A; Imam SS; Alharbi KS; Alotaibi NH; Alshehri S; Alhakamy NA; Alzarea AI; Afzal M; Elmowafy M
Int J Nanomedicine; 2020; 15():4717-4737. PubMed ID: 32636627
[TBL] [Abstract][Full Text] [Related]
15. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
16. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
[TBL] [Abstract][Full Text] [Related]
17. Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate.
Tan G; Yu S; Pan H; Li J; Liu D; Yuan K; Yang X; Pan W
Int J Biol Macromol; 2017 Jan; 94(Pt A):355-363. PubMed ID: 27760378
[TBL] [Abstract][Full Text] [Related]
18. Optimizing indomethacin-loaded chitosan nanoparticle size, encapsulation, and release using Box-Behnken experimental design.
Abul Kalam M; Khan AA; Khan S; Almalik A; Alshamsan A
Int J Biol Macromol; 2016 Jun; 87():329-40. PubMed ID: 26893052
[TBL] [Abstract][Full Text] [Related]
19. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
Fan W; Yan W; Xu Z; Ni H
Colloids Surf B Biointerfaces; 2012 Feb; 90():21-7. PubMed ID: 22014934
[TBL] [Abstract][Full Text] [Related]
20. Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel.
Al-Kassas R; Wen J; Cheng AE; Kim AM; Liu SSM; Yu J
Carbohydr Polym; 2016 Nov; 153():176-186. PubMed ID: 27561485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
